|
|
Vol. 14.09 – 15 May, 2025
|
|
|
|
|
|
|
|
Investigators highlighted the coordination of innate and adaptive immune response/evasion during LUAD precancer evolution and suggested TIM-3 as a potential target for LUAD precancer interception. [Cancer Cell]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
The authors demonstrated that the let-7 miRNA family plays a homeostatic role in alveolar type 2 (AT2) quiescence by preventing the uncontrolled accumulation of AT2 transitional cells and promoting AT1 differentiation.
[Nature Communications]
|
|
|
|
|
|
Scientists identified hedgehog-interacting protein, associated with both bronchopulmonary dysplasia and emphysema, as a critical regulator of alveologenesis.
[Science Advances]
|
|
|
|
|
|
Researchers uncovered differential expression of a specific set of miRNAs, piRNAs, snoRNAs, vault RNAs, Y RNAs, and lincRNAs, which inhibit apoptosis while promoting cell proliferation and viral infection.
[Molecular Therapy-Nucleic Acids]
|
|
|
|
|
|
Investigators tested the hypothesis that mice deficient in arginase-2 exposed to hyperoxia would have attenuated lung inflammation and injury compared to similarly exposed wild-type mice.
[American Journal of Physiology-Lung Cellular and Molecular Physiology]
|
|
|
|
|
|
|
|
Proteomic and biochemical analyses indicate ST6GalNAc-I mediated NECTIN2 sialylation in LUAD cells. ST6GalNAc-I–deficient tumor cells cocultured with T cells are more susceptible to T cell–mediated tumor cell killing.
[Journal of Clinical Investigation]
|
|
|
|
|
|
Researchers identified that smoking modulates lung cancer cell metabolism through altered protein post-translational modification.
[Cancer Research]
|
|
|
|
|
|
Through systematic screening and verification, investigators identified a role for the long noncoding RNA MYLK-AS1 supporting acquired tyrosine kinase inhibitor resistance in lung cancer.
[Cancer Research]
|
|
|
|
|
|
Scientists showed that treatment with a dopamine D2 receptor agonist reduces tumor angiogenesis in multiple in vivo xenograft models of human small cell lung cancer.
[Cell Death & Disease]
|
|
|
|
|
|
The authors defined a novel nuclear factor erythroid 2-related factor 2 (NRF2) target gene set linked to NRF2-dependency in cancer cell lines, and observed that a significant portion of these genes is devoid of promoter-proximal NRF2 occupancy. [EMBO Reports]
|
|
|
|
|
|
|
|
|
Investigators address the complexities of PD-L1 IHC in cytology, focusing on validation guidelines, quality assessment, cyto-histological correlation, and interobserver variability. [Acta Cytologica]
|
|
|
|
|
|
|
|
Imperative Care, Inc. announced the completion of patient enrollment in its SYMPHONY-PE Study, a pivotal Investigational Device Exemption trial evaluating the safety and efficacy of the company’s Symphony Thrombectomy System for the treatment of acute pulmonary embolism. [Imperative Care, Inc.]
|
|
|
|
|
|
|
|
June 24-27, 2024 Heidelberg, Germany and Virtual
|
|
|
|
|
|
|
|
|
|
|
3IA Côte d’Azur – Valbonne, France
|
|
|
|
|
|
|
Princeton University – Princeton, New Jersey, United States
|
|
|
|
|
|
|
University of Newcastle – Callaghan, Australia
|
|
|
|
|
|
|
Indiana University School of Medicine – Indianapolis, Indiana, United States
|
|
|
|
|
|
|
Technische Universität Dresden – Dresden, Germany
|
|
|
|
|
|